#85 Research Authority
Peer-reviewed research curated for clinical relevance and evidence quality.
Recent research digest. 4 of 4 most recent studies from our monitored feeds.
Correlates and Predictors of Criminal Legal Involvement in People With First-Episode Psychosis.
Scanlon Faith et al.
The Journal of clinical psychiatry • 2026
# Clinical Summary This study examined criminal justice involvement in people experiencing their first episode of psychosis and identified rates, risk factors, and predictors of such involvement both before and during a two-year treatment period. Understanding these patterns helps clinicians recognize which early psychosis patients may be at higher risk for legal involvement so they can implement appropriate preventive interventions.
CB1 receptor signaling at the cingulate-striatal circuit is anxiogenic.
Kelly Thomas J et al.
Nature communications • 2026
# Clinical Summary Researchers discovered that cannabinoid receptor activation in the brain circuit connecting the anterior cingulate cortex to the striatum suppresses neural activity and produces anxiety-like effects in animals. This finding explains why high doses of THC cause anxiety by identifying the specific brain pathway and molecular mechanism responsible for this adverse effect.
Higher THC Concentration Medicinal Cannabis Products Efficacy and Safety Considerations: A Rapid Review.
Graham Myfanwy et al.
Drug and alcohol review • 2026
# Clinical Summary This rapid review examined medicinal cannabis products with high THC concentration and minimal CBD content, evaluating their effectiveness and safety for adult use in the Australian market. The study systematically analyzed evidence from 2014-2024 to inform clinical decision-making about high-potency THC cannabis products.
The association between major depressive disorder and cannabis use disorder: A meta-analysis and meta-regression analysis.
Pini Alemar João et al.
Journal of psychiatric research • 2026
# Clinical Summary People with cannabis use disorder are significantly more likely to have major depressive disorder than the general population, and this relationship appears to work both ways, with depression increasing the risk of developing cannabis problems. The strength of this association varies across different studies and populations, suggesting that factors like treatment setting, geographic location, and how depression and cannabis use are measured all influence whether these two conditions occur together.
Digest generated April 09, 2026 at 03:02 PM